Prevention of melatonin suppression by nocturnal lighting: Relevance to cancer

European Journal of Cancer Prevention

Volumn 16, Issue 4, 2007, Pages 357-362

  Kayumov, Leonid ^a,b   Lowe, Alan ^a,b   Rahman, Shadab A ^a   Casper, Robert F ^c   Shapiro, Colin M ^a,b,c,d  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

Low wavelength bright light; Melatonin; Nocturnal lighting

Indexed keywords

MELATONIN;

ADULT; ARTICLE; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; FILTER; HUMAN; HUMAN EXPERIMENT; ILLUMINATION; LIGHT; MALE; MELANOMA; NIGHT; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RETINA;

ADULT; ANIMALS; ASIAN CONTINENTAL ANCESTRY GROUP; CIRCADIAN RHYTHM; HUMANS; LIGHTING; MALE; MELATONIN; NEOPLASMS;

EID: 34547447598     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cej.0000215622.59122.d4     Document Type: Article

References (39)

1. Ahmed S, Cutter N, Lewy AJ (1995). Phase response curve of low-intensity green light in winter depressives. Sleep Res 24:508.
2. Althuis MD, Dozier JM, Anderson WF, Devesa SS, Brinton LA (2005). Global trends in breast cancer incidence and mortality 1973-1997. Int J Epidemiol 34:405-412.
3. Anisimov VN, Alimova IN, Baturin DA, Popovich IG, Zabezhinski MA, Manton KG, et al. (2002). The effect of melatonin treatment regimen on mammary adenocarcinoma development in HER-2/neu transgenic mice. Int J Cancer 103:300-305.
4. Aoki H, Yamada N, Ozeki Y, Yamane H, Kato N (1998). Minimum light intensity required to suppress nocturnal melatonin concentration in human saliva. Neurosci Lett 252:91-94.
5. Beniashvili DS, Benjamin S, Baturin DA, Anisimov VN (2001). Effect of light/dark regimen on N-nitrosoethylurea-induced transplacental carcinogenesis in rats. Cancer Lett 163:51-57.
6. Claustrat B, Kayumov L, Pandi-Perumal SR (2002). Dual role of melatonin: a hormone and a drug? In: Haldar C, editor. Treatise on pineal gland and melatonin. Enfield: Science Publishers. pp. 543-553.
7. Cohen M, Lippman M, Chabner B (1978). Role of pineal gland in aetiology and treatment of breast cancer. Lancet 2:814-816.
8. Czeisler CA, Kronauer RE, Allan JS, Duffy JF, Jewett ME, Brown EN, et al. (1989). Bright light induction of strong (type 0) resetting of the human circadian pacemaker. Science 244:1328-1333.
9. Davis S, Mirick DK, Stevens RG (2001). Night shift work, light at night, and risk of breast cancer. J Natl Cancer Inst 93:1557-1562.
10. Feychting M, Osterlund B, Ahlbom A (1998). Reduced cancer incidence among the blind. Epidemiology 9:490-494.
11. Gooneratne NS, Metlay JP, Guo W, Pack FM, Kapoor S, Pack AI (2003). The validity and feasibility of saliva melatonin assessment in the elderly. J Pineal Res 34:88-94.
12. Hansen J (2001). Light at night, shiftwork, and breast cancer risk. J Natl Cancer Inst 93:1513-1515.
13. Horne JA, Ostberg O (1976). A self-assessment questionnaire to determine morningness-eveningness in human circadian rhythms. Int J Chronobiol 4:97-110.
14. Horowitz TS, Cade BE, Wolfe JM, Czeisler CA (2001). Efficacy of bright light and sleep/darkness scheduling in alleviating circadian maladaptation to night work. Am J Physiol Endocrinol Metab 281:E384-E391.
15. Ji BT, Devesa SS, Chow WH, Jin F, Gao YT (1998). Colorectal cancer incidence trends by subsite in urban Shanghai, 1972-1994. Cancer Epidemiol Biomarkers Prev 7:661-666.
16. Johns MW (1991). A new method for measuring daytime sleepiness: The Epworth Sleepiness Scale. Sleep 14:540-545.
17. Kayumov L, Casper RF, Hawa RJ, Perelman B, Chung SA, Sokalsky S, Shapiro CM (2005). Blocking low-wavelength light prevents nocturnal melatonin suppression with no adverse effect on performance during simulated shift work. J Clin Endocrinol Metab 90:2755-2761.
18. Khalsa SB, Jewett ME, Cajochen C, Czeisler CA (2003). A phase response curve to single bright light pulses in human subjects. J Physiol 549:945-952.
19. Lewy AJ, Cutler NL, Sack RL (1999). The endogenous melatonin profile as a marker for circadian phase position. J Biol Rhythms 14:227-236.
20. Lockley SW, Brainard GC, Czeisler CA (2003). High sensitivity of the human circadian melatonin rhythm to resetting by short wavelength light. J Clin Endocrinol Metab 88:4502-4505.
21. Martin SK, Eastman CI (2000). When is your DLMO? Sleep 23:A179.
22. Martin SK, Eastman CI (2002). Sleep logs of young adults with self-selected sleep times predict the dim light melatonin onset. Chronobiol Int 19:695-707.
23. Mettlin C (1999). Global breast cancer mortality statistics. CA Cancer J Clin 49:138-144.
24. Morita T, Tokura H, Wakamura T, Park SJ, Teramoto Y (1997). Effects of the morning irradiation of light with different wavelengths on the behavior of core temperature and melatonin in humans. Appl Human Sci 16:103-105.
25. Nagtegaal E, Peeters T, Swart W, Smits M, Kerkhof G, van der Meer G (1998). Correlation between concentrations of melatonin in saliva and serum in patients with delayed sleep phase syndrome. Ther Drug Monit 20:181-183.
26. Parker SL, Davis KJ, Wingo PA, Ries LAG, Heath CW (1998). Cancer statistics by race and ethnicity. CA Cancer J Clin 48:31-48.
27. 2: protection by melatonin and related molecules. J Pineal Res 29:54-61.
28. Reiter RJ (2002). Potential biological consequences of excessive light exposure: melatonin suppression, DNA damage, cancer and neurodegenerative diseases. Neuroendocrinol Lett 23:9-13.
29. Rotenberg VS, Kayumov L, Indursky P, Hadjez J, Kimhi R, Sirota P, et al. (1997). REM sleep in depressed patients: different attempts to achieve adaptation. J Psychosomat Res 42:565-575.
30. Schernhammer ES, Laden F, Speizer FE, Willett WC, Hunter DJ, Kawachi I, et al. (2003). Night-shift work and risk of colorectal cancer in the nurses' health study. J Natl Cancer Inst 95:825-828.
31. Shibui K, Uchiyama M, Okawa M, Kudo Y, Kim K, Liu X, et al. (2000). Diurnal fluctuation of sleep propensity and hormonal secretion across the menstrual cycle. Biol Psychiatry 48:1062-1068.
32. Skene DJ (2003). Optimization of light and melatonin to phase-shift human circadian rhythms. J Neuroendocrinol 15:438-441.
33. Thapan K, Arendt J, Skene DJ (2001). An action spectrum for melatonin suppression: evidence for a novel non-rod, non-cone photoreceptor system in humans. J Physiol 15:261-267.
34. van den Heiligenberg S, Depres-Brummer P, Barbason H, Claustrat B, Reynes M, Levi F (1999). The tumor promoting effect of constant light exposure on diethylnitrosamine-induced hepatocarcinogenesis in rats. Life Sci 64:2523-2534.
35. Vijayalaxmi, Reiterm RJ, Sewerynek E, Poeggeler B, Leal BZ, Meltz ML (1995). Marked reduction of radiation-induced micronuclei in human blood lymphocytes pretreated with melatonin. Radiat Res 143:102-106.
36. Zeitzer JM, Dijk DJ, Kronauer R, Brown E, Czeisler CA (2000). Sensitivity of the human circadian pacemaker to nocturnal light: melatonin phase resetting and suppression. J Physiol 526:695-702.
37. Zhou JN, Liu RY, van Heerikhuize J, Hofman MA, Swaab DF (2003). Alterations in the circadian rhythm of salivary melatonin begin during middle-age. J Pineal Res 34:11-16.
38. Zhao ZY, Xie Y, Fu YR, Bogdan A, Touitou Y (2002). Aging and the circadian rhythm of melatonin: a cross-sectional study of Chinese subjects 30-110 yr of age. Chronobiol Int. 19:1171-1182.
39. Zhao ZY, Xie Y, Fu YR, Li YY, Bogdan A, Touitou Y (2003). Circadian rhythm characteristics of serum cortisol and dehydroepiandrosterone sulfate in healthy Chinese men aged 30 to 60 years. A cross-sectional study. Steroids 68:133-138.